Cancer Cachexia Market to Reach USD 2.93 Billion by 2027; Rapid Inclination towards Combination Therapies to Aid Growth: Fortune Business Insights™

Key Companies Profiled are Bristol-Myers Squibb Company, ANI Pharmaceuticals, Inc., Merck & Co., Inc., Hikma Pharmaceuticals PLC, Mylan N.V., AbbVie, Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd. and other key market players.

Pune, July 10, 2020 (GLOBE NEWSWIRE) -- The global cancer cachexia market is anticipated to gain traction from the rising shift of the healthcare providers towards combination therapies. Such therapies are aiding in improving the lean body mass (LBM) of patients. This information is given by Fortune Business Insights™ in a recently published report, titled, “Cancer Cachexia Market Size, Share & Covid-19 Impact Analysis, By Product (Progestogens, Corticosteroids, Combination Therapies, and Others), By Distributional Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further states that this market size was USD 2.02 billion in 2019 and is projected to reach USD 2.93 billion by 2027, thereby exhibiting a CAGR of 4.8% during the forecast period.

Request a Sample Copy of the Research Report:

This Report Answers the Following Questions:

  • What are the market drivers, dynamics, and hindrances?
  • How will the COVID-19 pandemic affect the market in the coming years?
  • Which strategies are presently adopted by the companies to intensify competition?
  • What are the estimated, current, and historical sizes of the market?
  • Which region is set to dominate the market in terms of revenue?

Drivers & Restraints-

Rising Incidence of Cancer Cachexia to Skyrocket Demand

The rising prevalence of cachexia, as well as cancer is further creating a huge patient pool requiring treatment for the same. The Society on Sarcopenia, Cachexia, and Wasting Disorders (SCWD), a non-profit organization, mentioned in a report that in the developing nations, approximately 0.5-1.0% of the total population suffer from cancer cachexia.

Besides, the World Health Organization (WHO) declared that around 18.1 million new cases of cancer were reported in 2018 globally. These researches prove that the demand for cancer cachexia therapeutics is set to surge in the near future. However, the strict government rules and regulations regarding the clinical trials of new candidates may hamper the cancer cachexia market growth in the coming years.

The emergence of the COVID-19 pandemic has brought the entire world to a standstill. The governments of several countries have implemented lockdown measures to prevent the spread of this deadly infection. Such initiatives have caused disruptions in the production and supply chain. But, with time and perseverance, we will be able to battle this severe phase and come back to normalcy. Our authentic reports would help you to receive in-depth information about the present scenario of every market so that you can adopt the necessary strategies accordingly.

To get to know more about the short-term and long-term impacts of COVID-19 on this market,

please visit:

How Will the Outbreak of COVID-19 Affect the Global Market?

  • Patients living with chronic diseases, such as cancer cachexia are at high risk of catching the coronavirus infection.
  • It is likely to occur as these patients tend to suffer from multiple comorbidities.
  • In Italy, a retrospective analysis was conducted by taking 355 patients under consideration who expired because of COVID-19. Out of those, 20.0% patients were suffering from cancer.
  • These factors are propelling numerous medical associations to implement stringent guidelines for the healthcare workers and cancer patients.
  • They are advising to utilize telehealth for receiving supportive care and treatment.


Progestogens Segment to Dominate Owing to Their Cost-effective Nature

In terms of products, the market is segregated into combination therapies, corticosteroids, progestogens, and others. Out of these, the progestogens segment is in the dominant position in terms of the cancer cachexia market share. This growth is attributable to the higher efficiency of progestogens in this treatment. They are also cost-effective, as compared to the other products.

Regional Analysis-

North America to Lead Backed by Presence of Favorable Reimbursement Policies

Geographically, in 2019, North America procured USD 0.80 billion in terms of revenue. The region is likely to lead the market throughout the forecast period. This growth is attributable to the increasing awareness programs amongst the masses about the benefits of supportive care for cancer. Apart from this, the presence of favorable reimbursement policies in the developed countries, such as Canada and the U.S. would contribute to the growth of the market in this region.

Europe is expected to exhibit a considerable CAGR in the coming years owing to the high demand for the treatment of cancer cachexia. Asia Pacific, on the other hand, is set to grow significantly fueled by the increasing investments by the prominent companies present in the region in research and development activities.

Quick Buy -  Cancer Cachexia Market Research Report:

Competitive Landscape-

Key Players to Invest Hefty Amounts in R&D for Creating Novel Drugs

The global market is presently underpenetrated with the presence of very few companies worldwide. This is mainly occurring because of the lack of approved therapeutics for this treatment. However, some of the companies are investing in R&D activities to come up with new drug candidates. Below are two of the latest industry developments:

  • July 2019: Mylan N.V., and Pfizer Inc., entered into a definitive agreement to form a new company named Viatris. It would help both companies to fulfill the growing demand for innovative treatment options from the patients, as well as broaden their access to medicines.

  • November 2019: Bristol-Myers Squibb Company successfully acquired Celgene Corporation to create a strong biopharma company. As per the officials of Bristol, its expertise in the fields of cardiovascular disease, hematology, immunology, and oncology would aid in transforming the lives of the patients through technological advancements.

Fortune Business Insights™ presents a list of all the providers operating in the global Cancer Cachexia Market. They are as follows:

  • Bristol-Myers Squibb Company, New York, U.S.
  • ANI Pharmaceuticals, Inc., Baudette, U.S.
  • Merck & Co., Inc., Kenilworth, U.S.
  • Hikma Pharmaceuticals PLC, London, U.K.
  • Mylan N.V., Pennsylvania, U.S.
  • AbbVie, Inc., North Chicago, U.S.
  • Pfizer Inc., New York, U.S.
  • Teva Pharmaceutical Industries Ltd., Petach-Tikva, Israel

Have Any Query? Ask Our Experts:

Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptionss
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Cancer Cachexia, for Key Regions/ Country, 2019
    • Pipeline Analysis, By Key Players
    • Overview of Economic Cost Burden of Cancer & Supportive Care, for Key Regions/ Country
    • Key industry Developments – Mergers, Acquisition, Etc.
  • Global Cancer Cachexia Market Analysis, Insights and Forecast, 2016-2027
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Product
      • Progestogens
      • Corticosteroids
      • Combination Therapies
      • Others
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Rest of World

TOC Continued….!!!

Request for Customization:

Have a Look at Related Reports:

Skin Cancer Treatment Market Size, Share & Industry Analysis, By Disease Indication (Melanoma and Non-Melanoma), By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Radiation Therapy), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2027

Breast Cancer Therapeutics Market Size, Share and Global Trend By Therapy (Targeted Therapy, Hormonal Therapy, Chemotherapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Cancer Type (Hormone Receptor, HER2+), and Geography Forecast till 2026

Lung Cancer Therapeutics Market Size, Share and Global Trend By Therapy (Targeted, Therapy, Immunotherapy, Chemotherapy), By Cancer Type (Non-small cell lung cancer (NSCLC), Small cell lung cancer (SCLC)), By Distribution Channel(Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography Forecast till 2026

Cancer Biomarkers Market Size, Share & Industry Analysis, By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, and Others), By Biomarker Type (PSA, HER-2, EGFR, KRAS, and Others), By End User (Pharmaceutical & Biotechnology Companies, Diagnostics & Research Laboratories, Hospitals & Specialty Clinics, and Others), and Regional Forecast, 2019-2026

Cancer Cryotherapy Market Size, Share and Global Trend By Product (Cryoablation System, Cyroablation Needles, Cyroprobes), By Disease Indication (Retinoblastoma, Skin Cancer, Prostate Cancer,Cervical Cancer, Actinic Keratosis, Bone Cancer), By End User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers) and Geography Forecast till 2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: